Latest Articles
28. 02. 2020
List of reimbursed medicinal products valid as of 1.3.2020
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...
31. 01. 2020
List of reimbursed medicinal products valid as of 1.2.2020
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...
31. 12. 2019
List of reimbursed medicinal products valid as of 1.1.2020
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...
29. 11. 2019
List of reimbursed medicinal products valid as of 1.12.2019
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...
29. 11. 2019
Requirement for Marketing Authorisation Holders to Evaluate the Risk of the Presence of Nitrosamines
In compliance with the procedure outlined under Art. 5(3) of Regulation (EC) no. 726/2004, holders of marketing authorisations of human medicinal products containing...
06. 11. 2019
Correction of the List of reimbursed medicinal products valid as of 6.11.2019
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...
31. 10. 2019
List of reimbursed medicinal products valid as of 1.11.2019
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...
cz
